Patents by Inventor Ewa BRZOZOWSKA

Ewa BRZOZOWSKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12153047
    Abstract: The method according to the invention enables the confirmation of infections/carriage caused by Streptococcus agalactiae bacterial species. The method employs a specific reaction of selected epitopes that are part of immunoreactive proteins of clinical isolates of Streptococcus agalactiae with antibodies present in the serum.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: November 26, 2024
    Assignees: UNIWERSYTET JAGIELLONSKI, INSTYTUT IMMUNOLOGII I TERAPII DOSWIADCZALNEJ POLSKIEJ AKADEMII NAUK
    Inventors: Monika Brzychczy-Wloch, Anna Dobrut, Sabina Gorska, Ewa Brzozowska, Andrzej Gamian
  • Publication number: 20210033607
    Abstract: The method according to the invention enables the confirmation of infections/carriage caused by Streptococcus agalactiae bacterial species. The method employs a specific reaction of selected epitopes that are part of immunoreactive proteins of clinical isolates of Streptococcus agalactiae with antibodies present in the serum.
    Type: Application
    Filed: January 9, 2019
    Publication date: February 4, 2021
    Inventors: Monika Brzychczy-Wloch, Anna DOBRUT, Sabina GORSKA, Ewa BRZOZOWSKA, Andrzej GAMIAN
  • Patent number: 10048263
    Abstract: The method of the invention allows confirmation of infections caused by Streptococcus agalactiae bacterial species. The method employs a specific reaction of immunoreactive proteins obtained from clinical isolates of Streptococcus agalactiae with antibodies present in the serum of patients.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: August 14, 2018
    Assignees: Uniwersytet Jagiellonski, Instytut Immunologii I Terapii Doswiadczainej Im. Ludwika Hirszfelds Pan
    Inventors: Monika Brzychczy-Wloch, Sabina Górska, Ewa Brzozowska, Andrzej Gamian, Piotr Heczko
  • Publication number: 20160377613
    Abstract: The method of the invention allows confirmation of infections caused by Streptococcus agalactiae bacterial species. The method employs a specific reaction of immunoreactive proteins obtained from clinical isolates of Streptococcus agalactiae with antibodies present in the serum of patients.
    Type: Application
    Filed: March 28, 2014
    Publication date: December 29, 2016
    Inventors: Monika BRZYCHCZY- WLOCH, Sabina GÓRSKA, Ewa BRZOZOWSKA, Andrzej GAMIAN, Piotr HECZKO